General Discussion, page-1661

@Dkjuggler good question – I don’t recall hearing anything since late last year.

In any case my recollection from Q3/22 was that DT mentioned ALS had an additional dedicated REE XRF-line (ME-XRF30) up and running to assist with sample turnaround. There was also mention that they were looking to streamline the assay process to include/add Nb, Ti, and P into the standard REE package.

But, I don’t recall any mention that this additional instrument was exclusive (or even prioritised, unless they pay premium) to DRE – my understanding was that it was just ALS’s solution to help with back log and the forecast numbers (i.e. dedicated to REE samples in general). Could be wrong - keen to hear others take on it.

So, my suspicion is that ALS (along with the other labs) are still swamped – based on the sheer increase in asx announcements with ‘REE’ in the title.